StockNews.com Lowers Rigel Pharmaceuticals (NASDAQ:RIGL) to Hold
Rigel Pharmaceuticals (NASDAQ:RIGL – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday. A number of other equities research analysts also recently issued reports on the stock. Cantor Fitzgerald increased their price objective on shares of Rigel Pharmaceuticals […]